Press Release

Platelet Rich Plasma Market to Expand with Increasing Demand for Cosmetic Surgeries

Platelet Rich Plasma Market Top Leading Countries, Share, Consumption, Drivers, Trends, Industry Analysis, and Global Forecast 2026

Platelet Rich Plasma Market The Global Platelet Rich Plasma (PRP) Market is set to grow on account of increase in the occurrence of orthopedic and sports injuries. Key insights have been shared by Fortune Business Insights in its report, titled “Platelet Rich Plasma Market Size, Share And Global Trend By Origin (Allogeneic, Autologous, Homologous), By Type (Pure PRP, Leukocyte rich PRP, Leukocyte rich fibrin), By Application (Orthopaedic surgery, Cosmetic surgery, General surgery, Neurosurgery, Others), And Geography Forecast Till 2026”. The reports analyses the different factors influencing the growth of this market during the forecast period. Plasma is a part of blood that contains proteins that help in clotting of blood and support cell growth. Platelet-rich plasma is a substance that is injected into the body to accelerate healing. The basic idea is to stimulate the body to grow new and healthy cells by injecting the platelet-rich plasma into it. Cases where platelet-rich plasma injections are used include hair growth, tendon injuries, osteoarthritis, and post-surgical repair. It has also been applied to reduce inflammation and promote tissue healing.

Browse Full [email protected]

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

  • Adistem Ltd
  • DePuy Synthes Companies
  • Arthrex
  • Stryker
  • Isto Biologics
  • Cesca Therapeutics Inc.
  • Nuo Therapeutics, Inc.
  • Stryker Sage

Increase in Demand for Cosmetic Surgeries to Aid Growth in the Market

The global platelet rich plasma market is set to experience rapid growth owing to the rise in demand for cosmetic surgeries in the forecast period. This is expected mainly due to the potential held by platelet-rich plasma in catalyzing the healing process of tissues. The significance of the technology is also rising in post-surgical repair processes involved in treating orthopaedic disorders. For example, doctors have met with considerable success after injecting patients with osteoarthritis in the knees. Besides these factors, platelet-rich plasma is finding increasing demand in the treatment of chronic diseases such as cardiovascular and neurovascular diseases.

A similar trend is seen in the global platelet rich plasma market with regard to sports injuries. The market size is expected to expand on account of rising sports injuries and the need for sportspersons to heal quickly. For example, sportsmen like Tiger Woods and Rafael Nadal have been known to use platelet-rich plasma injections to accelerate the healing process.

Thus, large scale applicability of the platelet-rich plasma technology is treating a variety of diseases and injuries is accelerating the growth of the global platelet rich plasma market.

Get PDF Brochure of this [email protected]

Quality and Cost Issues Hampering the Rise of the Market

While the global platelet rich plasma market is on the threshold of experiencing rapid growth, it has to overcome certain hurdles. These are mainly in the form of high costs platelet-rich plasma therapies and poor quality control of test results. Moreover, the US Food and Drug Administration has not yet approved of the platelet-rich plasma treatments. Such hindrances are hampering the smooth rise of the global platelet rich plasma market.


By Origin

  • Allogeneic
  • Autologous
  • Homologous

By Type

  • Pure PRP
  • Leukocyte rich PRP
  • Leukocyte rich fibrin

By Application

  • Orthopaedic surgery
  • Cosmetic surgery
  • General surgery
  • Neurosurgery
  • Others

By Geography

  • North America (USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Stiff Competition in This Nascent Market

Competition in the global platelet rich plasma market has come to be characterised by mergers and acquisitions, and innovations. For example, the US-based Regenexx acquired another US-based company, Harbour View Medical Services, in 2017. In terms of innovation, the market players are getting fiercer. This was seen in 2016 when Alliance Partners received FDA approval for their Cyclone Platelet Rich Plasma (PRP) Concentrating System. Competition driven by innovation and diversification of product portfolios through mergers and acquisitions is expected to aid the growth of the global platelet rich plasma market in the forecast period.

More Trending Topics from Fortune Business Insights:

Spinal Fusion Devices Market Global Share, Growth, Outlook, Size, Opportunities, Trends, Regional Overview, and 2026 Forecast

Potential Opportunities of Vaccines Market Size Overview by Industry Trends, Share, Growth Factor and Forecast to 2026

Contact Lenses Market Showing Impressive Growth by 2026 | Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *